New Key Statistics Module, Z-Score and F-Score
OTCPK:BRIBF Key Ratios
Market Cap $ M | 101.53 |
Enterprise Value $ M | -230.02 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.25 |
Price/Sales | 1,070.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.05 |
Beneish M-Score | 103.06 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 6.15 |
EV-to-EBITDA | 6.50 |
PEG | -- |
Shares Outstanding M | 730.99 |
Net Margin (%) | -28,329.48 |
Operating Margin % | -88,269.04 |
Pre-tax Margin (%) | -29,875.56 |
Quick Ratio | 37.81 |
Current Ratio | 37.81 |
ROA % (ttm) | -8.47 |
ROE % (ttm) | -8.64 |
ROIC % (ttm) | -101.44 |
Dividend Yield % | -- |
Altman Z-Score | 4.22 |
BRIBF Number of Guru Trades
BRIBF Volume of Guru Trades
Gurus Latest Trades with OTCPK:BRIBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BRIBF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Brii Biosciences Ltd Insider Transactions
No Available Data
News about OTCPK:BRIBF
Total 0- 1